The SCORPION trial compared perioperative and survival outcome of primary debulking surgery (PDS) versus neo-adjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) in high tumor load advanced epithelial ovarian cancer patients (AEOC)